Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On FOX 50 at 10: UNC student found dead in South Africa. How students at the Morehead-Cain scholar's high school will honor her
Program
On WRAL at 6 : Unhealthy ingredients in kids' food. 5 On Your Side reveals the findings of a local scientist who researched hundreds of products from local shelves.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
113.70
-0.45 (-0.39%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,403,409
Open
113.75
Bid (Size)
113.50 (1)
Ask (Size)
114.13 (2)
Prev. Close
114.15
Today's Range
113.20 - 114.16
52wk Range
89.67 - 121.64
Shares Outstanding
1,750,942,289
Dividend Yield
1.79%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst
September 19, 2024
Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech growth and attractive valuation.
Via
Benzinga
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
September 19, 2024
Via
Benzinga
Performance
YTD
+3.50%
+3.50%
1 Month
+0.90%
+0.90%
3 Month
+7.98%
+7.98%
6 Month
+3.35%
+3.35%
1 Year
+16.65%
+16.65%
More News
Read More
20 S&P 500 Stocks That Move The Most When The Fed Starts Cutting Interest Rates
September 18, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Top 3 Dividend Stocks to Beat Market Volatility and Boost Returns
September 17, 2024
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Why ABBOTT LABORATORIES (NYSE:ABT) should be investigated by quality investors.
September 11, 2024
Via
Chartmill
Looking Into Abbott Laboratories's Recent Short Interest
August 29, 2024
Via
Benzinga
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
September 16, 2024
Via
The Motley Fool
Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?
September 16, 2024
Via
The Motley Fool
3 Stocks to Buy and Hold Forever
September 14, 2024
Via
The Motley Fool
3 Ultra-Safe Dividend Stocks for Retirees to Buy and Hold
September 13, 2024
Via
The Motley Fool
2 Stocks That Are Passive Income Machines to Buy and Hold Forever
September 11, 2024
Via
The Motley Fool
Medtronic Stock: Growth On Rise of the Cardiovascular Machines
September 09, 2024
Via
MarketBeat
Abbott Laboratories Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
August 22, 2024
Via
Benzinga
Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle Libre 3 Glucose Monitoring System
September 05, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Abbott's 'Transformative' Move And Answer To Dexcom's Newest Device
September 05, 2024
Via
Investor's Business Daily
Patchy But Still Bullish
September 02, 2024
Via
Talk Markets
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
August 30, 2024
Via
The Motley Fool
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
August 26, 2024
Via
Benzinga
Dexcom's Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients
August 26, 2024
Via
Benzinga
Will New 'Milestone' Glucose Monitor Help Dexcom Stock Bounce Back?
August 26, 2024
Via
Investor's Business Daily
This Is Great News for Medtronic, but Is It Time to Buy the Stock?
August 26, 2024
Via
The Motley Fool
Donald Trump Owns These 21 Dividend Kings. Should You?
August 26, 2024
Via
The Motley Fool
Topics
Government
Exposures
Political
3 Unstoppable Dividend Stocks to Buy Right Now
August 25, 2024
Via
The Motley Fool
Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally
August 23, 2024
Via
MarketBeat
Exposures
Product Safety
Abbott Laboratories, Nu Holdings And More On CNBC's 'Final Trades'
August 22, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.